Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

NCT04812366 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT04812366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04812366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
Lead sponsor
University of British Columbia
Phase
Phase 2
Overall status
Recruiting
Start date
September 21, 2021
Completion date
June 1, 2027
Enrollment
315 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer